Skip to main content

Genome Canada to Fund Genomics, Personalized Health Grants

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome Canada is making plans to launch a new large-scale program focused on genomics and medicine that will provide between C$40 million (US$39 million) and C$65 million for projects lasting up to four years.

According to Genome Alberta, the Genomics and Personalized Health program is expected to launch either by the end of this year or in the beginning of 2012, but final details about the program are not yet available.

The program will fund research projects that focus on using genomics-based health studies that will help contribute to an evidence-based and more cost-effective health system, according to Genome Alberta's website.

Researchers receiving the funding will be expected to acquire matching funds from another supporter, and Genome Canada will provide up to 50 percent of proposed budgets of up to $5 million.

The University of Toronto also has posted some information on its website about the Genomics and Personalized Health program, noting that it will include funding for three programs at the Ontario Genomics Institute. These include a program to fund high-impact, high-risk and early stage technology development, a precommercialization and business development fund to help researchers move innovations toward the market, and a genomics capacity building workshop program.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.